Market Insight - Power of observation propels comparative effectiveness research into the mainstream
This article was originally published in Scrip
Executive Summary
US agencies are making inroads in the use of comparative effectiveness research to support more robust decision-making. Observational studies are an emerging force in this area and promise to overcome some of the limitations of randomised clinical trials. Such studies have enjoyed some success in fields including cancer, cardiovascular disease and diabetes. Yet some stakeholders fear the advent of the rationing of care, explain Dr Richard Gliklich and Michelle Leavy.